BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Phaseolus vulgaris {Boston bean} - Bacteroides ovatus |
👶
Relandscaping the Gut Microbiota with a Whole Food: Dose-Response Effects to Common Bean. Foods (Basel, Switzerland) (Foods ) Vol: 11 Issue 8 Pages: Pub: 2022 Apr 15 Epub: 2022 Apr 15 Authors Lutsiv T , McGinley JN , Neil-McDonald ES , Weir TL , Foster MT , Thompson HJ , Html Article Publication |
| Phaseolus vulgaris {Boston bean} - Bacteroides ovatus |
👶
Anti-obesity effects of a-amylase inhibitor enriched-extract from white common beans (Phaseolus vulgaris L.) associated with the modulation of gut microbiota composition in high-fat diet-induced obese rats. Food & function (Food Funct ) Vol: 11 Issue 2 Pages: 1624-1634 Pub: 2020 Feb 26 Epub: Authors Shi Z , Zhu Y , Teng C , Yao Y , Ren G , Richel A , Publication Publication |
| Phaseolus vulgaris {Boston bean} - Bacteroides ovatus |
👶
Polysaccharides from red kidney bean alleviating hyperglycemia and hyperlipidemia in type 2 diabetic rats via gut microbiota and lipid metabolic modulation. Food chemistry (Food Chem ) Vol: 404 Issue Pt A Pages: 134598 Pub: 2023 Mar 15 Epub: 2022 Oct 14 Authors Bai Z , Huang X , Wu G , Ye H , Huang W , Nie Q , Chen H , Yin J , Chen Y , Nie S , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
